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Prevalence, prenatal diagnosis and clinical features
of oculo-auriculo-vertebral spectrum: a registry-based
study in Europe
Ingeborg Barisic*,1, Ljubica Odak1, Maria Loane2, Ester Garne3, Diana Wellesley4, Elisa Calzolari5,
Helen Dolk2, Marie-Claude Addor6, Larraitz Arriola7, Jorieke Bergman8, Sebastiano Bianca9, Berenice Doray10,
Babak Khoshnood11, Kari Klungsoyr12, Bob McDonnell13, Anna Pierini14, Judith Rankin15, Anke Rissmann16,
Catherine Rounding17, Annette Queisser-Luft18, Gioacchino Scarano19 and David Tucker20
Oculo-auriculo-vertebral spectrum is a complex developmental disorder characterised mainly by anomalies of the ear, hemifacial
microsomia, epibulbar dermoids and vertebral anomalies. The aetiology is largely unknown, and the epidemiological data are
limited and inconsistent. We present the largest population-based epidemiological study to date, using data provided by the
large network of congenital anomalies registries in Europe. The study population included infants diagnosed with oculo-auriculo-
vertebral spectrum during the 1990–2009 period from 34 registries active in 16 European countries. Of the 355 infants
diagnosed with oculo-auriculo-vertebral spectrum, there were 95.8% (340/355) live born, 0.8% (3/355) fetal deaths, 3.4%
(12/355) terminations of pregnancy for fetal anomaly and 1.5% (5/340) neonatal deaths. In 18.9%, there was prenatal
detection of anomaly/anomalies associated with oculo-auriculo-vertebral spectrum, 69.7% were diagnosed at birth, 3.9% in the
first week of life and 6.1% within 1 year of life. Microtia (88.8%), hemifacial microsomia (49.0%) and ear tags (44.4%) were
the most frequent anomalies, followed by atresia/stenosis of external auditory canal (25.1%), diverse vertebral (24.3%) and eye
(24.3%) anomalies. There was a high rate (69.5%) of associated anomalies of other organs/systems. The most common were
congenital heart defects present in 27.8% of patients. The prevalence of oculo-auriculo-vertebral spectrum, defined as microtia/
ear anomalies and at least one major characteristic anomaly, was 3.8 per 100 000 births. Twinning, assisted reproductive
techniques and maternal pre-pregnancy diabetes were confirmed as risk factors. The high rate of different associated anomalies
points to the need of performing an early ultrasound screening in all infants born with this disorder.
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INTRODUCTION
Oculo-auriculo-vertebral spectrum (OAVS) (OMIM 164210,
OMIM 141400) is a complex developmental disorder that mainly
affects head and neck structures derived from the first and second
branchial arches and the intervening first pharyngeal pouch and
branchial cleft. It is characterised by anomalies of the ear,
hemifacial microsomia, epibulbar dermoids and vertebral anoma-
lies.1–3 Other terms, such as Goldenhar syndrome, hemifacial
microsomia, lateral facial dysplasia, oculo-auriculo-vertebral
dysplasia, facio-auriculo-vertebral spectrum/sequence and first
and second branchial arch syndrome are also used, but it is now
accepted that these conditions are part of the same clinical
spectrum that varies from mild-to-severe phenotype.3–5
The causes of OAVS are unknown but undoubtedly complex and
heterogeneous. Genetic as well as environmental causative factors
have been proposed. Different chromosomal anomalies have been
identified by standard karyotyping or array comparative genomic
hybridisation in OAVS patients.6,7 The association with chromosomes
5, 9, 18, 22 and X was observed on several occasions.3 There are three
reports that link OAVS with 14q22.3-q23.3 region. One patient
and his father both had branchio-oto-renal syndrome and
OAVS associated with an 11.79-Mb duplication of chromosome
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14q22.3-q23.3 and a 4.38-Mb deletion in 13q21.31-q21.32.8 Northrup
et al9 have described a patient with per inv(14)(p11.2q22.3) inherited
from his phenotypically normal mother. Recent publication describes
a new familial 14q23.1 duplication, 1.34 Mb in size, which segregates
with the OAVS phenotype in an autosomal dominant manner.10
These findings indicate that disruption of potential candidate gene/
genes in 14q22.3–q23.3 region could be a causative factor in at least
some of the OAVS cases. A genome-wide linkage analysis in one
family identified Goosecoid mapped at 14q32.1 as a possible candidate
gene, but no pathogenetic mutation was found.11A more recent
genome-wide association study also failed to identify a clear causative
variant.12 Fischer et al13 found abnormal expression of BAPX1 gene
(mapped at 4p15.3) in a significant number of OAVS patients and
suggested that epigenetic disregulation of BPAX1 and possibly other
genes might have a role in the aetiology of OAVS. The epigenetic
changes could explain the higher incidence of twinning, high
proportion of discordant monozygotic twins and high correlation
of use of in vitro fertilisation in OAVS.14
The condition usually occurs sporadically, but familial cases
compatible with autosomal dominant15,16 and autosomal
recessive2,17 types of inheritance have been described. The
possibility of germinal mosaicism has also been considered.18 The
low empiric recurrence risk of 2–3% and the rarity of reports of
concordance in twins support the multifactorial type of inheritance in
most cases.3
The OAVS has been linked with intrauterine exposure to many
different drugs. In particular, maternal use of vasoactive medications
in combination with cigarette smoking in the first trimester was
found to be associated with an increased risk of OAVS.19 Vasoactive
medications reported more often in OAVS pregnancies compared
with controls include pseudoephedrine, phenylpropanolamine,
aspirin, and ibuprofen, but clear association was demonstrated only
for pseudoephedrine.19 Severe manifestations of OAVS were also
observed in a cocaine-exposed infant.20
In fact, it was previously suggested that disturbance in vascular
supply to cephalic neural crest cells could hinder embryonic develop-
ment in the branchial arches and cause OAV spectrum.21
Twin pregnancies19,22,23 and the use of artificial reproductive
techniques (ART)14,24 have been observed more often than expected
among OAVS patients. The relationship with maternal diabetes
contributes additionally to the heterogeneity of environmental
causes associated with OAVS.25 As the aetiology is largely unknown,
data on the possible environmental risk factors from epidemiological
studies are needed.
Although several large clinical series of OAVS patients have been
published discussing the classification, clinical presentation, diagnos-
tic criteria and associated findings,2,4,5 population-based
epidemiological studies on OAVS are lacking, because they demand
large populations, standardised data collection and genetic expertise.
There has been considerable discrepancy in the reported prevalence
rates that range from 1 per 56422 to 1 per 45 000.26 Most data are
based on live born (LB) children, while little is known about fetal
deaths (FDs) and terminations of pregnancy for fetal anomaly
(TOPFA) after prenatal ultrasound diagnosis. In addition, hospital-
based series of patients from specialised centres bring ascertainment
biases in prevalence data and frequency of associated abnormalities.
In this study, we used data from EUROCAT, a large network of
population-based congenital anomaly registries in Europe, to provide
population-based information on OAVS patients, including the total
prevalence and birth outcomes (proportion of LB, FD at gestational
age (GA)Z20 weeks, TOPFA), time of diagnosis, sex, GA and weight
at birth, associated anomalies, family history, consanguinity and
possible risk factors. To our knowledge, this is the largest series of
OAVS patients published so far.
MATERIAL AND METHODS
The EUROCAT congenital anomaly registries are surveying 41.7 million
births per year (30% of the annual European birth population). They collect
data on all major structural congenital anomalies, chromosomal abnormalities
and genetic syndromes for all birth outcomes. The registries are based on
multiple sources of information that include hospital records, birth and death
certificates, cytogenetic reports and post mortem examinations. A detailed
description of registries, methods of case ascertainment, data collection and
processing is available elsewhere27 (http://www.eurocat-network.eu/content/
DQI-2010.pdf). For the purpose of this study, we used data provided by 34
registries from 16 European countries for the 1990–2009 period. Data was
extracted from the central database in January 2013.The central EUROCAT
database was searched for ICD9/BPA (756060, 75606), ICD10/BPA (Q8704)
and OMIM (164210, 141400) codes assigned to cases of OAVS/Goldenhar/
hemifacial microsomia. For the inclusion in the study or minimal diagnostic
criteria, we used arbitrary definition of the presence of microtia/ear anomalies
and at least one major anomaly of the OAV spectrum. Isolated cases of
microtia or other minor craniofacial anomalies specified in the Minor
Anomalies for Exclusion list in the EUROCAT classification guidelines
(www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf) were not included.
EUROCAT registries do not collect data on laterality of malformations or
zygosity, thus we were not able to analyse our data set in this respect.
An associated anomaly was defined as a major structural anomaly other
than craniofacial and vertebral anomalies, which are usually considered to
be part of the classical OAVS. In 20/30 (66.6%) of EUROCAT registries,
clinical geneticists take part in the examination of most or all patients with
dysmorphic features and multiple anomalies, and in the remaining
registries clinical geneticists participate in the examination of selected
cases. Medical geneticist (IB) reviewed all records. Textual description was
also analysed in order to ensure all relevant clinical information. Local
registries were occasionally contacted for supplying additional information.
All phenotype and epidemiological data will be available to all phenotypic
databases (eg, OMIM or GeneReviews).
Statistical analysis
Descriptive data are presented as counts and percentages for categorical data,
and mean and 95% confidence interval based on Poisson’s distribution is used
for prevalence. Statistical testing was performed at P¼ 0.05 level of statistical
significance. Generalised Linear/Nonlinear model based on Poisson’s distribu-
tion was used for statistical testing of time trends in prevalence, Fisher’s exact
test for testing difference between categorical data and difference between two
proportions’ test for statistical testing between prenatal diagnosed and non-
diagnosed patients. Chi-squared test was performed in order to determine
differences in maternal age distribution between OAVS and other EUROCAT
cases.
RESULTS
We recorded a total of 355 cases of OAVS during the 20 years of study
period. There were 95.8% (340/355) LB, 0.8% (3/355) FDs, 3.4%
(12/355) TOPFA and 1.5% (5/340) neonatal deaths (Table 1). Of the
307 patients with a known time of diagnosis, 69.7% were diagnosed at
birth, 3.9% in the first week of life and 6.1% within 1 year of life.
In 18.9%, there was a prenatal detection of congenital anomaly/
anomalies, followed by the diagnosis of OAVS later on. The number
of prenatally detected cases increased to some extent from1990–1999
to 2000–2009 period, although not significantly (P¼ 0.27) (Table 1).
The mean GA at discovery of an anomaly by prenatal ultrasound was
21.3±4.1 (range 11–40) gestational weeks. Of the 58 prenatally
detected patients, there were 45 LB, 1 FD and 12 (20.7%) pregnancies
were terminated at 22.1±4.8 (range 17–36) gestational weeks.
Oculo-auriculo-vertebral spectrum
I Barisic et al
2
European Journal of Human Genetics
The diagnosis was confirmed by post mortem examination in 13 cases.
Prenatally suspected cases had a higher frequency of central nervous
system (P¼ 0.001), congenital heart (P¼ 0.009), genitourinary
(P¼ 0.001) and spine (P¼ 0.02) anomalies compared with those
who had negative prenatal ultrasound scan. In addition, there were
significantly more cases with two or more major congenital anomalies
compared with patients who were detected after birth (P¼ 0.004).
In 16/108 (14.8%) cases, a major structural anomaly was detected
postnatally following a negative prenatal ultrasound result.
Detailed clinical description was available for 259 patients, and the
frequencies of observed anomalies are presented in Table 2. Microtia
(88.8%), hemifacial microsomia (49.0%) and ear tags (44.4%) were
most frequent, followed by atresia/stenosis of external auditory canal
(25.1%), diverse vertebral (24.3%) and eye (24.3%) anomalies and
orofacial clefts (17.8%).
There were 180 (69.5%) OAVS patients with anomalies other than
craniofacial and vertebral anomalies, which are usually considered to
be part of classical OAVS. One associated major anomaly was present
in 111 (61.7%), two anomalies in 54 (30%) and three or more
associated anomalies in 15 (8.3%) patients. The most common
anomaly was congenital heart defect present in 72 (27.8%) patients.
The frequency of a particular type of cardiac anomalies did not differ
from the frequency in the general population of the EUROCAT
registries included in the study for the same period, with the
exception of conotruncal defects (P¼ 0.02). Congenital heart defects
were not significantly associated with pulmonary (P¼ 0.68) or renal
(P¼ 0.34) abnormalities.
Epidemiological data
Prevalence was calculated based on data from 16 registries with non-
chromosomal syndrome prevalence above the EUROCAT average of
7.8 per 1000 in order to secure a high rate of ascertainment of
cases (http://www.eurocat-network.eu/content/DQI-2010.pdf). In the
period from January 1990 to December 2009 in these registries, we
recorded 161 cases in the population of 4 245 519 births. The
estimated prevalence is thus 1 per 26 370 or 3.8 per 100 000 births.
The prevalence rates for 1990–1999 and 2000–2009 were 2.8 and 4.3
per 100 000 (P¼ 0.008), respectively (Table 3).
The characteristics of OAVS patients observed in all 34 registries are
shown in Table 4. The male-to-female ratio was 1.4:1. The mean GA
in live births was 38.1±6.2 in females and 38.9±4.1 in males, while
the mean birth weight was 2971±769 g in females and 2940±769 g in
males.
The mean maternal age was 29.9±4.8 years and the mean paternal
age 32.1±6.4 years. Comparison of the maternal age distribution with
the maternal age distribution in the total EUROCAT population (data
known for 67.6% of the EUROCAT total birth population) yielded a
significant difference (P¼ 0.04), mothers of OAVS patients being
more represented in the Z30-year-old group compared with the rest
of EUROCAT population.
There were 11 confirmed familial OAVS cases, 3 of these among
sibs and 8 cases where one of the parents was affected. No phenotypic
differences between familial and sporadic cases were observed.
Parental consanguinity was recorded in two cases.
Karyotyping was performed in 54.8% (155/283) of cases and
yielded two abnormal findings (47,XXY and 45,X/46,XY). Data on
FISH analyis for del22q11.2 were not available.
No evidence of exposure to consistent teratogenic agents was
noted, including data on medications that were available for 70
patients. The use of vasoactive drugs was recorded in six cases.
Multiple pregnancies of undetermined zygosity were recorded in 25
(7.2%) cases (in all cases, only one affected of twins/triplets), and
15/172 (8.7%) patients were conceived by one of the methods of ART.
Maternal diabetes was present in 3.9% (6/152) of the affected
pregnancies (Table 4).
DISCUSSION
Prevalence
The usually cited prevalence of OAVS is 1 per 5600,2 although others
have suggested much lower figures in the range of 1 per 10 000,30
1 per 19 500,31 1 per 26 55032 to 1 per 45 000.26 The prevalence of
1 per 26 370 found in our study is more in line with these results. The
observed significant increase in the prevalence observed comparing
1990–1999 and 2000–2009 may be due to the better ascertainment of
cases or to the true increase in prevalence of this condition and
should be investigated further.
There is no universal agreement upon minimal diagnostic criteria
for OAVS, but an ear anomaly has been suggested by some authors as
the mildest form.2–5,19 As EUROCAT registries do not record cases
with isolated minor anomalies of the head and neck, our series of
OAVS patients did not include the possible mild cases presenting only
as microtia or some other minor/cosmetic ear defect. According to our
case definition, only patients with ear anomaly and at least one major
craniofacial and/or vertebral feature involved in OAVS were included
in the study. Therefore, the prevalence of 1 per 26 370 in EUROCAT
registries represents a minimum figure and refers to a clinically
relevant/serious group of patients. In addition, OAVS patients who
are diagnosed at a later age will be missed, as some registries only
register cases with anomalies discovered in the neonatal period.
Clinical features
Premature birth, low birth weight and failure to thrive have been often
reported in infants with OAVS. In a demographic study of OAVS,
Werler et al23 found that 20% of cases weighed o2500 g at birth,
compared with only 5% of controls. In our patient series, 20.8% of
males and 36.7% of females weighedo2500 g. More than two-thirds of
both sexes had normal GA at birth. The observed male preponderance
is in accordance with observations from previous studies.3–5,19
The diagnosis of OAVS relies on the recognition of the characteristic
craniofacial, ear, eye and vertebral defects and in most cases is
Table 1 Prenatal detection rate and outcome of pregnancies with oculo-auriculo-vertebral spectrum (OAVS) in the EUROCAT registries,
1990–2009
Monitored period Total births
Total no.
of patients
Prenatally detected/number of
patients with available data
Prenatal detection rate,
(%) 95% CI LB FD TOPFA
1990–1999 4 639 123 125 18/113 15.9 (10.0–24.3) 119 2 4
2000–2009 9 114 383 230 40/194 20.6 (15.3–27.1) 221 1 8
1990–2009 13 753 506 355 58/307 18.9 (14.8–23.8) 340 3 12
Abbreviations: FD, fetal death; LB, live born; TOPFA, terminations of pregnancy for fetal anomaly.
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Table 2 Type and frequency of anomalies among patients with oculo-auriculo-vertebral spectrum (OAVS)
Type of anomaly
Patients
N¼259 (%)
Rollnick et al,4
N¼294
Vento et al,28
N¼154
Tasse et al,5
N¼53
Toulitaou et al,29
N¼17
Ear 259 (100) 294 (100) 53 (100) 17 (100)
Microtia/misshapen/dysplastic/rudimentary eara 230 (88.8) 16 (94)
Preauricular skin taga 115 (44.4) 61 (39.6) 10 (59)
Atresia/stenosis of external auditory canal 65 (25.1) 9 (53)
Absence of auricle 24 (9.3)
Accessory auricle 23 (8.9)
Anotia 17 (6.6)
Preauricular pits/sinusa 6 (2.3)
Other 17 (6.6)
Eye 63 (24.3) 52 (18) 13 (24.5)b 11 (65)
Epibulbar dermoids 20 (7.7) 9 (4.4) 32 (20.7) 11 (20.7) 2 (12)
Epicanthusa 14 (5.4) 12 (75)
Microphthalmia 14 (5.4) 5 (9.4) 6 (35)
Coloboma of eyelid 10 (3.9) 4 (7.5) 2 (12)
Coloboma of iris 4 (1.5) 1 (6)
Anophthalmia 4 (1.5) 2 (3.7)
Aniridia 1 (0.4)
Absence of lens 1 (0.4)
Other 8 (3.1)
Orofacial clefts 46 (17.8) 66 (22) 21 (40) 5 (29)
Cleft lip and palate 21 (8.1) 21 (7) 5 (9.4)
Cleft palate 17 (6.6) 45 (15) 5 (9.4)
Cleft lip 7 (2.7) 2 (3.7)
Orofacial clefts, other 11 (4.2) 9 (16.9)
Face and neck 145 (56.0) 13 (76)
Hemifacial microsomia, including asymmetry
of the facea, micrognathia, mandibular
hypoplasia, and anomalies of jaw size
127 (49.0) 202 (68.7) 44 (83) 10 (59)
Anomalies of the nose 9 (3.5) 1 (6)
Facial palsy 9 (3.5) 24 (45)
Branchial cysta 9 (3.5)
Macrostomiaa 6 (2.3) 95 (61.6)
Tongue anomaly 4 (1.5)
Vertebral 63 (24.3) 55 (18.7) 29 (18.8) 10 (19) 3 (18%)
Cervical 17 (6.6)
Cervical anomaly NOS 10 (3.9)
Hemivertebre cervical 4 (1.5)
Split cervical vertebrae 1 (0.4)
Fussed cervical vertebrae 2 (0.8)
Thoracic/lumbar/sacral 13 (5.0)
Thoracic vertebrae anomaly NOS 8 (3.1)
Lumbar vertebrae anomaly NOS 2 (0.8)
Accessory lumbar vertebrae 1 (0.4)
Agenesis lumbar vertebrae 1 (0.4)
Sacral agenesis 1 (0.4)
Hemivertebrae NOS 14 (5.4)
Spine scoliosis 8 (3.1)
Spine NOS 18 (6.9)
Rib anomalies 18 (6.9) 12 (7.8)
Congenital heart defects 72 (27.8) 14 (5) 8 (15) 3 (18)
Ventricular septal defect 31 (12.0) 5 (9.4)
Atrial septal defect 13 (5.0)
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Table 2 (Continued)
Type of anomaly
Patients
N¼259 (%)
Rollnick et al,4
N¼294
Vento et al,28
N¼154
Tasse et al,5
N¼53
Toulitaou et al,29
N¼17
Pulmonary valve stenosis 8 (3.1)
Atrioventricular septal defect 6 (2.3) 1 (1.8)
Dextrocardia 6 (2.3) 1 (1.8)
Transposition of great arteries 4 (1.5)
Tetralogy of Fallot 4 (1.5)
Aortic valve stenosis 3 (1.2) 1 (1.8)
Coarctation of aorta 3 (1.2) 1 (1.8)
Hypoplastic aorta 3 (1.2)
Double outlet right ventricle 2 (0.8)
Hypoplastic left heart syndrome 1 (0.4)
Aortopulmonary window 1 (0.4)
Abnormal subclavian artery 1 (0.4)
Congenital heart disease, NOS 4 (1.5)
Respiratory system 13 (5.0) 2 (0.6) -
Choanal atresia 4 (1.5)
Lobar anomaly of the lungs 4 (1.5)
Lung hypoplasia 4 (1.5)
Tracheomalaciaa 1 (0.4)
Laryngomalaciaa 1 (0.4)
Digestive system 20 (7.7) 6 (2) 2 (12)
Oesophageal atresia with tracheo-oesophageal fistula 7 (2.7)
Anorectal stenosis/atresia 4 (1.5)
Imperforate anus 3 (1.2)
Diaphragmatic hernia 2 (0.8)
Pyloric stenosisa 2 (0.8)
Annular pancreas 1 (0.4)
Small intestine stenosis 1 (0.4)
Hirschsprung’s disease 1 (0.4)
Genitourinary 41 (15.8) 16 (5) 9 (16.9) 4 (23)
Renal agenesis, unilateral 12 (4.6) 2 (3.7)
Anomalies of ureter 9 (3.5)
Congenital hydronephrosis 8 (3.1) 1 (18)
Renal hypoplasia/dysplasia 7 (2.7) 1 (1.8)
Hypospadias 7 (2.7) 2 (3.7)
Cystic kidney 3 (1.2)
Horseshoe kidney 2 (0.8)
Duplex kidney 1 (0.4)
Cyst of urachus 1 (0.4)
Limb defects 30 (11.6) 33 (11) 26 (16.8) 6 (11.3) 4 (23)
Polydactyly 7 (2.7)
Radial defects of hands 6 (2.3)
Congenital hip dislocation 5 (1.9)
Pes equinovarus 4 (1.5)
Syndactyly 4 (1.5)
Bifid thumb 3 (1.2)
Camptodactyly 2 (0.8)
Low set thumbsa 2 (0.8)
Pes calcaneovalgus 1 (0.4)
Forearm anomalies NOS 3 (1.2)
Nervous system 27 (10.4) 38 (13) 8 (15) 5 (29)c
Neural tube defects (including encephalocele) 6 (2.3)
Hydrocephaly 5 (1.9) 1 (1.8)
Ventriculomegaly 5 (1.9) 1 (1.8)
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quite straightforward in spite of the clinical variability and possible
overlap with other entities (eg, CHARGE syndrome, Treacher Collins
syndrome, VACTERL association). Ear anomalies were present in all
recorded patients, ranging from mild deformities in the size and shape
of the external ear, preauricular tags and pits to anotia. The frequency
and type of ear anomalies, facial asymmetry and eye anomalies are
similar to data reported by others.4,5
Vertebral defects were reported in 18–60% of patients with
OAVS.2,4,5,28,29,33 The frequency of spine anomalies in previously
published OAVS cohorts depends on the sample size, patient selection
and the level of spine investigation. We recorded spinal anomalies in
24.3% of cases. Vertebral anomalies occurred at all levels of spinal
column, although slightly more frequently in the cervical region. The
association of ocular and vertebral anomalies reported by Gibson
et al33 was not observed.
Associated anomalies
We found 69.4% of OAVS patients to have associated anomalies. This
is the highest rate of anomalies not involving the head, neck and
vertebral column reported in OAVS so far. The high rate of associated
anomalies can be explained by the fact that we were able to present
data on all types of birth, including TOPFA, FD and early deaths.
In addition, existing studies have been small and/or from specialised
centres, which can cause ascertainment bias towards a specific group
of anomalies. There are only two detailed clinical reports with a large
number of patients. Grabb2 has reported seven associated anomalies
among 102 patients. Here the under-reporting could be due to the
limited diagnostic possibilities in those times. Rollnick et al4 found
44% of associated anomalies in a large series of 294 patients, but the
study included mild cases, with isolated microtia being present in
31% of cases. Excluding these, the proportion of associated anomalies
would be in line with our findings.
We observed not only a high rate but also a vast range of defects of
different organs and systems. The most frequent associated anomalies
were congenital heart defects present in almost one-third of patients.
The reported prevalence of congenital heart defects among OAVS
patients ranges from 1 to 58%.2,4,26,29,34 These differences are related
to the sample size and different methodology of respective studies.
Grabb2 found only one heart anomaly among 102 patients. Rollnick
et al4 included mild cases and found that only 4 and 5% of cases had
a congenital heart defect, respectively. On the other hand, heart
defects were found in a half of patients in the series coming from
cardiac department.35 In our study, the conotruncal anomalies were
significantly associated with OAVS as observed previously by some
authors,34,36 while the prevalence of other types of congenital heart
defects did not differ from the EUROCAT general population. The
congenital heart defects were not associated with pulmonary and
renal abnormalities, as observed by Kumar et al.36
Genitourinary malformations were the second most common
group of anomalies in our cohort (15.8%), with renal agenesis and
ureteral anomalies being most frequent. The presence of genitour-
inary defects reported in OAVS patients ranges from 2–5%2,4 to 50%
in a small study where 14 urinary tract anomalies (of these five cases
of renal agenesis) were diagnosed in 28 children with OAVS by
performing imaging of the urinary tract.37 This indicates that a more
detailed investigation may reveal that genitourinary anomalies are
more common than expected.
The frequency of central nervous system anomalies found in our
study (10.4%) is lower than that described in the literature, where
frequencies were reported that range between 13 and 47%.4,5,38 The
highest frequency was found by Rosa et al38 who included only subjects
undergoing neuroimaging and detected anomalies in 47% of patients.
We did not confirm the association between central nervous system
anomalies and ophthalmologic anomalies observed previously.5,38
OAVS with radial defect (OMIM 141400), which is considered a
separate entity among OAVS, was present in only six patients. In our
data set, we did not find cases that were diagnosed as oculo-auriculo-
fronto-nasal syndrome (OMIM (%601452), a rare developmental
field defect that combines abnormal development of the first and
second branchial arches with abnormal morphogenesis of the
frontonasal and maxillary processes.39,40
The broad spectrum of associated major anomalies reinforces the
heterogeneity of OAVS supporting the hypothesis that OAVS could be
part of the axial mesodermal dysplasia spectrum.41
Prenatal diagnosis
In order to delineate the pattern of anomalies detected prenatally
in OAVS, Castori et al42 reviewed prenatal ultrasound findings in
20 previously reported cases. They found asymmetric facial defects
Table 2 (Continued)
Type of anomaly
Patients
N¼259 (%)
Rollnick et al,4
N¼294
Vento et al,28
N¼154
Tasse et al,5
N¼53
Toulitaou et al,29
N¼17
Agenesis of corpus callosum 5 (1.9)
Agenesis/hypoplasia of cerebellum 4 (1.5)
Cerebral cyst 2 (0.8)
Aqueductus stenosis 1 (0.4)
Cerebral anomaly NOS 4 (1.5)
Situs viscerum inversus 1 (0.4)
Abbreviation: NOS, not otherwise specified; individuals with more than one anomaly within a category were counted only once.
aThese anomalies are considered minor according to the EUROCAT criteria and not are not systematically recorded in some registries.
bEpibulbar dermoids excluded.
cFacial nerve palsy included.
Table 3 Prevalence of oculo-auriculo-vertebral spectrum (OAVS) in
16 selected EUROCAT registries, 1990–2009
Monitored period Total births
Total no. of
patients
Birth prevalence per
100000 (95% CI)
1990–1999 1 775 132 49 2.8 (2.1–3.7)
2000–2009 2 596 179 112 4.3 (3.6–5.2)
1990–2009 4 245 519 161 3.8 (3.2–4.4)
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and central nervous system anomalies to be the most common
findings. In our group of OAVS patients, prenatally observed
anomalies were rather heterogeneous, affecting not only
craniofacial structures but also other organs and systems. In
more severe cases, the prenatal diagnosis is possible as early as
from 11 weeks of gestation.
Possible aetiology and risk factors
The aetiological heterogeneity and complexity of OAVS has been
suggested in many reports. Previous studies have occasionally
identified chromosomal abnormalities associated with OAVS. We
identified one patient with 47,XXY and one with 45,X/46,XY. Sex
chromosome aneuploidies have been described on several occasions
in patients with OAVS5,43,44 but as these aneuploidies are quite
frequent, the association with OAVS is possibly due to chance.
Although most cases were sporadic, 5.6% cases were familial,
confirming the existence of a small proportion of families with a
high recurrence risk.
Twin pregnancies were, on average, five times more common in
OAVS patients compared with the incidence of twin pregnancies in
European countries who participated in the study (the mean rate of
twin pregnancies was 14.9 per 1000 births, ranging from 11.2 in Italy
to 18.0 in Denmark).45 Several studies have reported an increased rate
of twinning in pregnancies with OAVS with and without infertility
treatment. Different possible mechanisms, including basic
common embryological, disruptive or epigenetic events, were
discussed.14,22,23,26 Because multiple gestations occur commonly in
couples treated for infertility, we also examined the use of ART.
Couples who had children with OAVS were treated more for infertility
than the general European population (15/172 or 8.7% compared
with the mean use of ART of 2.7%; range 1.2–4.9% in European
countries under study).46 An excess of patients with OAVS conceived
by ART has been also described before.14,47–49 At present, it is not
known whether the observed increased risk is due to the technique
itself or to the fertility problems in parents.14 Our data confirm the
observation that twinning and treatment for infertility are associated
with an increased risk of congenital anomalies in general50 and in
particular with OAVS, as proposed previously.14,23,24 The higher
maternal age observed among mothers of OAVS patients could be
also related to the higher rate of reproductive difficulties.
It was suggested that maternal diabetes may also be associated with
OAVS.25 It is estimated that 0.3% of all pregnant women have pre-
pregnancy diabetes.51 We found the number of mothers with pre-
pregnancy diabetes in OAVS pregnancies to be more than 10 times
higher, supporting the hypothesis that diabetes is a risk factor for this
developmental disorder.
Study strengths and limitations
This epidemiological population-based study is the largest to date and
the only one in which data on all types of birth outcomes is included.
The greatest strengths of this study are the large series of OAVS
patients and the use of multiple sources of ascertainment, which made
possible avoiding ascertainment bias found in the reports from
specialised centres.
However, in spite of the use of the same methodology, the possible
differences due to case ascertainment methods, data-coding practices
and true differences in the risk of OAVS among different populations
must be taken into consideration when combining epidemiological
data from many different registries. For example, the average age at
diagnosis varies according to the prenatal and early neonatal screening
and follow-up practices in each region. The different prenatal
ultrasound policies and possible differences in operators’ skill and
equipment can account for differences in prenatal detection rates
among different registries. Few registries report only cases up to 1
week of life and could miss patients diagnosed later on with milder
clinical presentation. Furthermore, there are differences in the
completeness and accuracy of case description and in the level of
genetic expertise. As registries are collecting limited set of routine
data, we were not able to consider all possible aetiological factors.
Another limitation is that mild cases of isolated microtia and other
minor ear anomalies are not included, which hampers comparison
with some of the studies. However, caution should be exercised when
comparing with other studies due to differences in methodology,
sample size, biases in patient selection and level of investigations of
internal organs/systems.
Table 4 Descriptive epidemiological data on patients with oculo-
auriculo-vertebral spectrum (OAVS) in the EUROCAT registries,
1990–2009
Characteristics
Number of OAVS
patients (%)
Sex
Male 205
Female 148
Unknown 2
Gestational age, week
n¼321 (live births with known
gestational age and sex)
M F
n¼188 n¼133
o37 33 (17.5%) 21 (15.8%)
37–41 147 (78.2%) 105 (78.9%)
Z42 8 (4.3%) 7 (5.3%)
Birth weight (g)
n¼320 (live births with known
gestational age and sex)
M F
n¼192 n¼128
o1500 9 (4.7%) 13 (10.1%)
1500–1999 13 (6.8%) 7 (5.5%)
2000–2499 18 (9.3%) 27 (21.1%)
2500–2999 39 (20.3%) 28 (21.9%)
3000–3499 71 (37%) 41 (32%)
43500 42 (21.9%) 12 (9.4%)
Positive family history 11/196 (5.6%)
Consanguinity 2/202 (1%)
Singleton pregnancies 322/347 (92.8%)
ART 10/158 (6.3%)
Multiple pregnancies 25/347 (23 twins,
2 triplets) (7.2%)
ART 5/14 (35.7%)
Maternal pregestational
diabetes
6/152 (3.9% )
Abbreviation: ART, assisted reproductive technology.
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The high rate of associated anomalies points to the need to
perform an early screening of the heart, kidneys and spine in all
infants born with this disorder. Early diagnosis, long-term multi-
disciplinary follow-up and genetic counselling of affected families are
needed for optimal patient management.
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